A Buyer's Checklist for Research Peptides in Australia

Most of what separates a defensible research-peptide purchase from a poor one can be checked before you place an order, from information a supplier either publishes or does not. The checklist below is written to be applied to any supplier in the Australian market, including this one. None of it requires laboratory access or specialist knowledge — it requires reading a certificate carefully and noticing what is missing from it.

For research use only — not for human or veterinary use. This page is general information about evaluating suppliers and documentation. It is not legal advice.

1. A named laboratory, not "an accredited third party"

"Independently tested" and "accredited third-party laboratory" are phrases, not facts. A verifiable claim names the laboratory. Once you have a name you can look up whether the laboratory exists, what it does, and whether it offers a way to confirm its own reports.

A supplier that will not name its testing laboratory has removed the only route you had to check anything. Treat the omission as the answer.

2. A batch number and a test date on the report

A Certificate of Analysis documents one lot of material, not a product line. Without a batch number the report cannot be tied to any particular vial, and without a test date you cannot tell whether it describes material produced last month or three years ago.

The follow-up question is the useful one: is this the batch I would actually receive? If not, ask for the report covering the lot that would ship. A supplier holding batch-specific documentation can produce it; one publishing a single certificate against a product page indefinitely probably cannot.

3. The analyte name matches the variant you are ordering

This catches more problems than any other single check, because research peptides routinely exist as closely related variants with different molecular weights and different literature:

• CJC-1295 with DAC versus CJC-1295 without DAC (modified GRF 1-29) — different molecules.
• TB-500 as the acetylated thymosin β4 sequence versus a TB-500 fragment.
• Semax versus N-acetyl semax amidate; Selank versus N-acetyl selank amidate.
• GHK versus GHK-Cu — a free tripeptide versus a copper complex, differing by roughly 18% on molecular weight.

If the analyte line on the certificate does not name the exact variant on the product page, the report is describing a different molecule, however good its figures look.

4. Per-component assay on blends

A single purity percentage on a two-peptide vial is not a meaningful quantity. Purity by area normalisation is one target peak's area over the total; with two intended peptides there is no single target, and reporting one peak as "purity" silently treats the other peptide as an impurity.

The correct treatment is a measured mass for each named component. A published example: a BPC-157 + TB-500 lot assaying 5.80 mg and 5.54 mg against a 5 mg + 5 mg label, and a CJC-1295 (mod GRF 1-29) + ipamorelin lot assaying 6.61 mg and 6.04 mg. Those figures also reveal the true ratio, which a combined percentage discards entirely. A supplier quoting one percentage for a blend has either tested a single component or produced a number that corresponds to nothing.

5. Both purity and assay, not one of them

Purity describes composition; assay describes quantity. A vial containing 6 mg of peptide against a 10 mg label can still be 99.8% pure — the shortfall is absent from the vial, not present as an impurity, so the chromatogram never shows it. Purity alone cannot detect underfill.

Ask for both, plus the label weight the assay is compared against. Identity confirmation by mass spectrometry completes the set: purity and assay both describe a peak, and only identity establishes that the peak is the molecule named.

6. A report identifier you can verify — or an honest statement about why not

A certificate hosted on a supplier's own website is an image, and images are editable. What makes a report checkable is a report or task identifier and verification key issued by the laboratory, which the laboratory holds in its own records and exposes through a lookup facility. Enter the identifier, retrieve the figures from the laboratory's side, compare.

Some certificates arrive with those fields redacted by an upstream supplier, along with client and manufacturer details. The analytical results on a redacted report are unchanged, but it cannot be independently confirmed from the image. The behaviour to look for is a supplier that says so rather than presenting a redacted report as verified. The Certificate of Analysis library marks each report accordingly.

7. AUD pricing and domestic dispatch

Practical, but not trivial. Pricing quoted in Australian dollars avoids conversion and foreign-transaction charges, and makes comparison between suppliers straightforward. Domestic dispatch avoids the international leg entirely — border screening, customs holds and return-to-sender outcomes are a real risk for imported research chemicals, and are administered separately from the therapeutic-goods framework, under customs law with its own permit requirements.

Domestic transit is also shorter, which matters for a thermolabile material. Ask where the material ships from, not merely where the website's currency selector points.

8. Storage and transit handling

Ask how material is stored before dispatch and what the supplier's position is on a temperature excursion in transit. Australian summer transit routinely exposes parcels to conditions well outside any manufacturer's storage specification, and a supplier with no stated position on that has not thought about it.

9. Confirm your own regulatory position

This one is on the buyer, and no supplier can do it for you. Australian regulation of these materials sits across three separate layers that are frequently conflated: the Therapeutic Goods Administration and the Poisons Standard at Commonwealth level; state and territory drugs-and-poisons legislation, which adopts and can vary the Standard; and import controls administered under customs law.

The consequence is that the same substance can carry different practical obligations in different states, and that scheduling changes over time. Some peptides correspond to Schedule 4 prescription-only substances; some appear in other schedules; some are not named in the Standard at all. The peptide regulations in Australia page explains how to look a compound up in the current Poisons Standard yourself, including why the Part 5 appendices matter as much as the schedule entry — which is the only method that stays correct as the Standard is amended.

10. Marketing that matches the labelling

The clearest signal of how carefully a supplier treats its obligations is whether its marketing tells the same story as its label. Research Use Only describes the terms of supply: no therapeutic claims, no representation as suitable for human or veterinary use, not registered on the ARTG, not assessed by the TGA for any therapeutic purpose.

A supplier labelling material RUO while publishing dosing protocols, administration routes, cycle guidance, before-and-after imagery or benefit claims is contradicting its own label. That is worth noticing for its own sake — and as a proxy. A supplier casual about the rules governing what it may say is not obviously rigorous about what is in the vial.

Applying it

The checklist is deliberately supplier-agnostic. Run it against TXLABS the same way: the laboratory is named, reports carry batch numbers and test dates, blends are reported per component, purity and assay appear separately, verification keys are published where held and redaction is disclosed where not, pricing is in AUD and dispatch is domestic. Where a report for a specific lot is not published, it can be requested. Details on ordering are on the buying research peptides in Australia page.

For research use only. Products supplied by TXLABS are laboratory research chemicals intended for in-vitro and laboratory research by qualified professionals. They are not medicines, supplements, foods or cosmetics, and are not for human or veterinary use.